BE899059A - BENZAMIDE DERIVATIVES - Google Patents

BENZAMIDE DERIVATIVES

Info

Publication number
BE899059A
BE899059A BE0/212488A BE212488A BE899059A BE 899059 A BE899059 A BE 899059A BE 0/212488 A BE0/212488 A BE 0/212488A BE 212488 A BE212488 A BE 212488A BE 899059 A BE899059 A BE 899059A
Authority
BE
Belgium
Prior art keywords
compounds
dichloro
benzamide derivatives
new
methylenedioxy
Prior art date
Application number
BE0/212488A
Other languages
French (fr)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BE899059A publication Critical patent/BE899059A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Parmi les composés de formule (I), sont nouveaux ceux où R1 représente un halogène, un cyano ou un trifluorométhyle en position para et R2 représente un hydrogène, ou bien où R1 et R2 représentent ensemble un 2,4-dichloro-, un 3,4-dichloro ou un 3,4-méthylènedioxy ; les composés encore nouveaux peuvent etre préparés par des procédés connus. Ces composés ainsi que leurs sels d'addition d'acides pharmaceutiquement applicables présentent, ayant une faible toxicité, des propriétés intéressantes d'inhibition de la monoamine oxydase et peuvent etre utilisés pour traiter les états dépressifs et la maladie de Parkinson.Among the compounds of formula (I), are new those where R1 represents a halogen, a cyano or a trifluoromethyl in the para position and R2 represents a hydrogen, or else where R1 and R2 together represent a 2,4-dichloro-, a 3 , 4-dichloro or 3,4-methylenedioxy; the still new compounds can be prepared by known methods. These compounds as well as their pharmaceutically applicable acid addition salts have, having a low toxicity, advantageous properties of inhibition of monoamine oxidase and can be used to treat depressive states and Parkinson's disease.

BE0/212488A 1983-03-03 1984-03-02 BENZAMIDE DERIVATIVES BE899059A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1150/83A CH653670A5 (en) 1983-03-03 1983-03-03 BENZAMIDE DERIVATIVES.

Publications (1)

Publication Number Publication Date
BE899059A true BE899059A (en) 1984-09-03

Family

ID=4203649

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/212488A BE899059A (en) 1983-03-03 1984-03-02 BENZAMIDE DERIVATIVES

Country Status (28)

Country Link
JP (1) JPS59167552A (en)
KR (1) KR910008202B1 (en)
AR (1) AR243155A1 (en)
AT (1) AT390948B (en)
AU (2) AU570431B2 (en)
BE (1) BE899059A (en)
CA (1) CA1252794A (en)
CH (1) CH653670A5 (en)
DE (1) DE3407654C2 (en)
DK (1) DK166382C (en)
ES (3) ES8504680A1 (en)
FI (1) FI79297C (en)
FR (1) FR2541996B1 (en)
GB (1) GB2135998B (en)
GR (1) GR81866B (en)
HU (1) HU193556B (en)
IE (1) IE57004B1 (en)
IL (1) IL71078A (en)
IT (1) IT1173365B (en)
LU (1) LU85231A1 (en)
MC (1) MC1568A1 (en)
NL (1) NL8400459A (en)
NO (1) NO165999C (en)
NZ (1) NZ207272A (en)
PH (1) PH19623A (en)
PT (1) PT78187B (en)
SE (1) SE466447B (en)
ZA (1) ZA841394B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1261335A (en) * 1984-08-29 1989-09-26 Hoffmann-La Roche Limited/Hoffmann-La Roche Limitee Ethylenediamine monoamide derivatives
US4772630A (en) * 1984-11-23 1988-09-20 Ciba-Geigy Corp. Benzamides and their salts
NZ219974A (en) * 1986-04-22 1989-08-29 Goedecke Ag N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases
FR2642972B1 (en) * 1989-02-14 1994-08-05 Inst Nat Sante Rech Med AGENTS FOR THE DIAGNOSIS AND TREATMENT OF MELANOMAS, HALOGENATED AROMATIC DERIVATIVES SUITABLE FOR USE AS SUCH AGENTS AND THEIR PREPARATION
WO2014155184A1 (en) * 2013-03-28 2014-10-02 Rhenovia Pharma Treatment for parkinson's disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342679A (en) * 1967-09-19 Parts by weight of acid chloride to react with parts of amine in
FR6557M (en) * 1967-06-20 1968-12-23 Ile De France
GB1455116A (en) * 1972-12-15 1976-11-10 Ici Ltd Pharmaceutical compositions
GB1520584A (en) * 1975-04-02 1978-08-09 Yamanouchi Pharma Co Ltd 2 - alkoxy - 5 substituted benzamide derivatives and their use in pharmaceutical compositions
DE2616486A1 (en) * 1976-04-14 1977-11-03 Basf Ag Perylene tetracarboxylic acid diimide pigments - for use in paints, thermoplastics, etc. and as vat dyes
CA1206964A (en) * 1980-11-12 1986-07-02 Nobuo Shinma Tetra-substituted benzene derivatives
DE3200258A1 (en) * 1982-01-07 1983-07-21 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München SUBSTITUTED 1-BENZOYL-2-PHENYLIMINO IMIDAZOLIDINE, THE ACID ADDITION SALTS THEREOF, METHOD FOR THE PRODUCTION THEREOF AND THE MEDICINAL PRODUCTS CONTAINING THE SAME
IL69997A0 (en) * 1983-01-03 1984-01-31 Miles Lab Procainamide and n-acetylprocainamide immunogens,antibodies prepared therefrom,labeled conjugates,and the use of such antibodies and labeled conjugates in immunoassays
US4808624A (en) * 1984-06-28 1989-02-28 Bristol-Myers Company Pharmacologically active substituted benzamides

Also Published As

Publication number Publication date
NZ207272A (en) 1987-07-31
GB2135998A (en) 1984-09-12
FI840734L (en) 1984-09-04
ES537045A0 (en) 1985-08-16
ES537046A0 (en) 1985-08-16
DK166382B (en) 1993-05-10
IL71078A (en) 1987-12-31
FR2541996A1 (en) 1984-09-07
ES8506600A1 (en) 1985-08-16
CA1252794A (en) 1989-04-18
FI840734A0 (en) 1984-02-22
IT1173365B (en) 1987-06-24
CH653670A5 (en) 1986-01-15
AU609758B2 (en) 1991-05-09
NO840797L (en) 1984-09-04
PH19623A (en) 1986-06-04
IE57004B1 (en) 1992-03-11
IL71078A0 (en) 1984-05-31
HU193556B (en) 1987-10-28
IE840512L (en) 1984-09-03
DK166382C (en) 1993-09-27
GB8405486D0 (en) 1984-04-04
JPH0430389B2 (en) 1992-05-21
FI79297B (en) 1989-08-31
IT8419778A0 (en) 1984-02-23
DK147584A (en) 1984-09-04
AU8307987A (en) 1988-06-16
DE3407654A1 (en) 1984-09-06
ES530230A0 (en) 1985-05-01
ZA841394B (en) 1985-06-26
NO165999C (en) 1991-05-15
JPS59167552A (en) 1984-09-21
AU570431B2 (en) 1988-03-17
PT78187A (en) 1984-04-01
ES8504680A1 (en) 1985-05-01
KR910008202B1 (en) 1991-10-11
LU85231A1 (en) 1985-09-12
MC1568A1 (en) 1985-02-04
ATA72484A (en) 1990-01-15
SE8401190L (en) 1984-09-04
AR243155A1 (en) 1993-07-30
DE3407654C2 (en) 1994-04-07
NO165999B (en) 1991-02-04
NL8400459A (en) 1984-10-01
DK147584D0 (en) 1984-02-29
FI79297C (en) 1989-12-11
AU2506684A (en) 1984-09-06
KR840009077A (en) 1984-12-24
SE466447B (en) 1992-02-17
GB2135998B (en) 1986-09-24
ES8506601A1 (en) 1985-08-16
AT390948B (en) 1990-07-25
PT78187B (en) 1986-08-05
GR81866B (en) 1984-12-12
SE8401190D0 (en) 1984-03-02
FR2541996B1 (en) 1987-12-11

Similar Documents

Publication Publication Date Title
GEP19960313B (en) Method for Production of Pyridin Derivatives
ATE36149T1 (en) ANTICONVULSIVE SULFAMATE DERIVATIVES.
CA2164638A1 (en) Novel erythromycin derivatives, method for preparing same and use thereof as drugs
BE903110A (en) ETHYLENEDIAMINEMONOAMIDE DERIVATIVES
BR9307387A (en) Therapeutic agents
PL254121A1 (en) A method of pyrazole analogs of mevalonolactone and their derivatives production
KR960000861A (en) Phenyl-substituted alkenylcarboguanides having perfluoroalkyl groups, methods for their preparation, their use as medicaments or diagnostic agents and medicaments containing them
FR2426694A1 (en) ADVANCED CEPHALOSPORINS, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
HUT46658A (en) Process for producing pharmaceutical compositions with lincotriene antagonist effect, comprising aromatic thioether derivatives as active ingredient
BE899059A (en) BENZAMIDE DERIVATIVES
JPS54160740A (en) Anti-fibrotic agent
ATE59632T1 (en) DIHYDRODIBENZOCYCLOHEPTYLIDENETHYLAMINE DERIVATIVES
MX2025010256A (en) Hydroquinazoline derivatives for the treatment of a disease or disorder
PT82032B (en) PROCESS FOR THE PREPARATION OF AMINO ACID DERIVATIVES WITH ANTICONVULSIVE ACA AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
DK562488D0 (en) PHARMACEUTICAL PREPARATION CONTAINING POLYMINE DERIVATIVES, AND SOME OF THESE POLYAMINE DERIVATIVES
KR910019964A (en) Hydrazone
IE42218L (en) Pyrazinoisoquinoline derivatives
BE905601A (en) DICHLOROANILINE DERIVATIVES.
Lippmann et al. Effects of the administration of epsilon amino caproic acid on catecholamine and serotonin levels in the rat and dog
PT77666A (en) PROCESS FOR THE PREPARATION OF NEW DERIVATIVES OF NITROSOUREE
CA2282666A1 (en) Novel erythromycin derivatives, method of preparation and application as medicines
EA200400470A1 (en) SUBSTITUTED DERIVATIVES ALKYLAMINOPIRIDAZINONE, METHOD OF THEIR RECEIVING AND CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS
LU83713A1 (en) PYRIMIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US4579870A (en) Aminoalkyl phenyl selenides for the treatment of hypertension and nervous system dysfunctions
CA2119661A1 (en) New n-benzylpiperazine compounds, their preparation process and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: F. HOFFMANN-LA ROCHE A.G.

Effective date: 19950331